Prelude Therapeutics (PRLD) Other Accumulated Expenses (2019 - 2026)
Prelude Therapeutics (PRLD) reported Other Accumulated Expenses of $911000.0 for Q1 2026, up 30.89% on a YoY basis from $696000.0 in Q1 2025, and down 5.6% sequentially from $965000.0 in Q4 2025.
Prelude Therapeutics (PRLD) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Prelude Therapeutics (PRLD) has 8 years of Other Accumulated Expenses data on file, last reported at $911000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 30.89% year-over-year to $911000.0; the trailing twelve-month figure through Mar 2026 stood at $911000.0 (up 30.89% YoY), and the FY2025 full-year result was $965000.0, up 25.16% from the prior year.
- Other Accumulated Expenses eased to $911000.0 in Q1 2026, from $965000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $965000.0 in Q4 2025 to a low of $175000.0 in Q3 2022.
- A 5-year average of $707411.8 and a median of $801000.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 1164.29% in 2022, while the deepest fall reached 69.3% in 2022.
- Tracing PRLD's Other Accumulated Expenses over 5 years: stood at $524000.0 in 2022, then soared by 80.34% to $945000.0 in 2023, then slipped by 18.41% to $771000.0 in 2024, then gained by 25.16% to $965000.0 in 2025, then fell by 5.6% to $911000.0 in 2026.
- Business Quant data shows PRLD's Other Accumulated Expenses at $911000.0 in Q1 2026, $965000.0 in Q4 2025, and $963000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 911,000.00 |
| Dec 31, 2025 | 965,000.00 |
| Sep 30, 2025 | 963,000.00 |
| Jun 30, 2025 | 861,000.00 |
| Mar 31, 2025 | 696,000.00 |
| Dec 31, 2024 | 771,000.00 |
| Sep 30, 2024 | 801,000.00 |
| Jun 30, 2024 | 455,000.00 |
| Mar 31, 2024 | 800,000.00 |
| Dec 31, 2023 | 945,000.00 |
| Sep 30, 2023 | 819,000.00 |
| Jun 30, 2023 | 809,000.00 |
| Mar 31, 2023 | 888,000.00 |
| Dec 31, 2022 | 524,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 289,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Sep 30, 2021 | 570,000.00 |
| Jun 30, 2021 | 29,000.00 |